Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

Fosinopril sodium - Generic Drug Details

« Back to Dashboard

What are the generic drug sources, and freedom to operate, for fosinopril sodium?

Fosinopril sodium is the generic ingredient in four branded drugs marketed by Apotex Inc, Bristol Myers Squibb, Actavis Labs Fl Inc, Invagen Pharms, Watson Labs, Teva, Aurobindo Pharma Ltd, Prinston Inc, Ranbaxy Labs Ltd, Upsher-smith Labs, Mylan, Emcure Pharms India, Sun Pharm Inds Ltd, Aurobindo Pharma, and Sandoz, and is included in twenty-two NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for fosinopril sodium. Seventeen suppliers are listed for this compound.

Summary for Generic Name: fosinopril sodium

Tradenames:4
Patents:1
Applicants:15
NDAs:22
Drug Master File Entries: see list6
Suppliers / Packagers: see list17
Bulk Api Vendors: see list57
Clinical Trials: see list924
Patent Applications: see list811
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:fosinopril sodium at DailyMed

Pharmacology for Ingredient: fosinopril sodium

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Emcure Pharms India
FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE
fosinopril sodium; hydrochlorothiazide
TABLET;ORAL079025-001Sep 17, 2010RXNoNo► Subscribe► Subscribe
Bristol Myers Squibb
MONOPRIL-HCT
fosinopril sodium; hydrochlorothiazide
TABLET;ORAL020286-002Nov 30, 1994DISCNYesNo► Subscribe► Subscribe
Emcure Pharms India
FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE
fosinopril sodium; hydrochlorothiazide
TABLET;ORAL079025-002Sep 17, 2010RXNoYes► Subscribe► Subscribe
Actavis Labs Fl Inc
FOSINOPRIL SODIUM
fosinopril sodium
TABLET;ORAL076620-003Oct 15, 2004DISCNNoNo► Subscribe► Subscribe
Ranbaxy Labs Ltd
FOSINOPRIL SODIUM
fosinopril sodium
TABLET;ORAL076580-002Apr 23, 2004DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: fosinopril sodium

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bristol Myers Squibb
MONOPRIL
fosinopril sodium
TABLET;ORAL019915-004Mar 28, 19954,384,123► Subscribe
Bristol Myers Squibb
MONOPRIL
fosinopril sodium
TABLET;ORAL019915-002May 16, 19914,337,201*PED► Subscribe
Bristol Myers Squibb
MONOPRIL
fosinopril sodium
TABLET;ORAL019915-003May 16, 19914,384,123► Subscribe
Bristol Myers Squibb
MONOPRIL
fosinopril sodium
TABLET;ORAL019915-003May 16, 19915,006,344*PED► Subscribe
Bristol Myers Squibb
MONOPRIL
fosinopril sodium
TABLET;ORAL019915-004Mar 28, 19954,337,201*PED► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc